[:en]Beximco signs deal with Serum Institute of India for COVID-19 vaccines[:]
[:en]Beximco would be the exclusive supplier in Bangladesh for the [...]
Primeira audiência pública do PL 399 é quase unânime no apoio à Cannabis
Com poucas vozes dissonantes, a maioria das manifestações de políticos [...]
Coronavirus Vaccine: Indians to get free shot in 73 days, says report
The trial process of India's first coronavirus vaccine -- Covishield -- is to be completed in next 58 days and it will be commercialised in 73 days, a top official at the Serum Institute of India said.
Novo teste para Covid-19 através da saliva
Em 15 de agosto, o órgão americano Food and Drug Administration (FDA) emitiu uma autorização de uso de emergência à Yale School of Public Health para a utilização do teste diagnóstico SalivaDirect COVID-19, um novo tipo de teste para detecção do vírus SARS-CoV-2 na saliva, o que poderia reduzir os custos e o tempo para processar os resultados.
Serum Institute to make up to 100 million COVID-19 vaccine doses for India, low-income countries by 2021
Serum Institute of India (SII) has announced that it has entered into a new partnership with Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation to accelerate the manufacture and delivery of upto 100 million doses of COVID-19 vaccines for India and low- and middle-income countries (LMICs).
Australia approves remdesivir as first treatment option for COVID-19
The Therapeutic Goods Administration (TGA), Division of the Australian Department of Health, has granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19. It has received provisional approval for use in adults and adolescent patients with severe COVID-19 symptoms who have been hospitalised.
